News from the College

Use the links below to read recent news and stories from the college.

  • Larner Researcher Leads Groundbreaking Study on Dual Tobacco Use
    September 16, 2024
    Larner College of Medicine Assistant Professor of Psychiatry and UVM Cancer Center member Elias Klemperer, Ph.D., alongside Co-PI Matthew Carpenter, Ph.D. from the Medical University of South Carolina (MUSC) have received a prestigious R01 grant from the National Institute on Drug Abuse (NIDA).
  • New Study in Radiology Shows Benefit of Ultrasound Screening for Some Women with Dense Breasts
    September 11, 2024
    Sprague's study, “Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort,” published recently in the Annals of Internal Medicine, found that false-positive mammogram results are discouraging many women from returning for important follow-up screenings. Researchers say the additional imaging or biopsies performed after a suspicious finding often cause significant anxiety.
  • UVMMC and Larner March for Pride and Equality
    September 9, 2024
    On Sunday, September 9, the Robert Larner, M.D. College of Medicine, in collaboration with the UVM Cancer Center, the College of Nursing and Health Sciences, UVM’s Prism organization, and the UVM Health Network, proudly participated in Burlington’s 41st annual Pride Parade.
  • Larner Medical Students Mentor Vermont Youth at Summer Health Institute
    September 5, 2024
  • Pulmonary Hypertension Care Center Accreditation Highlights Clinical Excellence
    September 3, 2024
  • Capturing a Picture of Health: VisualDx and Art Papier, M.D. '88
    August 18, 2024
    Art Papier, M.D.’88, was a first-year medical student when he attended a lecture by the late Lawrence Weed, M.D., which focused on the advantages of keeping detailed, shareable medical records to improve patient care. Papier was fascinated by Weed’s work. That fascination eventually led Papier to create a clinical decision tool that visually shows, describes, and categorizes thousands of diseases. The tool, VisualDx, today is used in clinics and medical schools throughout the nation and across the globe. It delivers time-sensitive, clinically relevant information for diagnosing and treating common and rare diseases and brings public health to the point of care.
  • Hands-On Learning: Medical Students Work with Patients Early in Curriculum
    September 1, 2024
    Larner students work with real patients in the first year of medical school. In Doctoring in Vermont, a course that pairs students with physicians in the community, they provide direct patient care and practice history-taking and examination skills. First-year students also shadow nurses in the hospital, investigate social determinants of health, and do clinical work in community settings.
  • UVM Cancer Center Trainee Spotlight – Deena Snoke, Ph.D.
    August 28, 2024
  • New Hope for Heart Failure: Larner College of Medicine Scientist’s Breakthrough Treatment
    August 20, 2024
    In a recent paper, titled “Vasohibin Inhibition Improves Myocardial Relaxation in Heart Failure with Preserved Ejection Fraction,” Matthew Caporizzo, Ph.D., assistant professor of Molecular Physiology & Biophysics, along with researchers at the University of Pennsylvania, have created a powerful small molecule vasohibin inhibitor (VASHi) to block MTN detyrosination in live animals. Detyrosination is the enzymatic removal of the tyrosine (an amino acid that is used by cells to build proteins) residue from the C-terminal end of tubulin (a protein that forms microtubules), which makes the microtubules sticky, impeding the heart cells from relaxing properly.
  • Paving the Way for Health Equity: UVM’s NAYR Program
    August 16, 2024
    Health equity improves when the health sciences workforce reflects the diversity of the community and health care systems invest in marginalized communities. The Robert Larner, M.D. College of Medicine at UVM, along with the College of Nursing and Health Sciences and the College of Education and Social Services, has recently been granted a substantial award by the National Institutes of Health (NIH)—an R25 Science Education Partnership Award (SEPA)—to sponsor a new mentorship and science enrichment cohort program, New American Youth on the Rise (NAYR), aimed at guiding girls from immigrant backgrounds into college careers in health sciences.